Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France.
about
Abiraterone for castration-resistant prostate cancer: adherence, survival and hospitalization : Analysis of a medical claims database.First Line Androgen Deprivation Therapy Duration Is Associated with the Efficacy of Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer after Docetaxel.Abiraterone Acetate: A Review in Metastatic Castration-Resistant Prostrate Cancer.Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study.Low-dose docetaxel, estramustine and prednisolone combination chemotherapy for castration-resistant prostate cancer.Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.Single institution long-term efficacy and safety analysis of abiraterone acetate (AA) in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) in a named patient programme (NPP).
P2860
Q33841309-11AFCD9A-4562-4955-B9A7-6ACB2F0D6570Q37638333-D96E9043-0E45-499C-B54F-57B8BA327209Q38618888-55C2729F-9CEF-49E1-8BD3-F43341578583Q41867950-76D5E984-9A4E-4568-9647-81665CA87D51Q42748400-9A526274-055A-4327-A872-2673581B87E0Q48167919-E84720D1-02A7-415F-B9CD-63A965A8EB60Q55153362-4F1AB8E5-56D3-40F8-8B06-AE611606ECA7
P2860
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Abiraterone acetate in patient ...... n for Use programme in France.
@ast
Abiraterone acetate in patient ...... n for Use programme in France.
@en
type
label
Abiraterone acetate in patient ...... n for Use programme in France.
@ast
Abiraterone acetate in patient ...... n for Use programme in France.
@en
prefLabel
Abiraterone acetate in patient ...... n for Use programme in France.
@ast
Abiraterone acetate in patient ...... n for Use programme in France.
@en
P2093
P2860
P1433
P1476
Abiraterone acetate in patient ...... n for Use programme in France.
@en
P2093
Aude Fléchon
Brigitte Laguerre
David Azria
Delphine Topart
Diego Tosi
Guilhem Roubaud
Gwenaëlle Gravis
Hanane Agherbi
Igor Latorzeff
Jean-Marc Ferrero
P2860
P2888
P356
10.1186/S12885-015-1257-2
P407
P577
2015-04-04T00:00:00Z
P5875
P6179
1023471892